Alkem Laboratories Ltd
NSE:ALKEM

Watchlist Manager
Alkem Laboratories Ltd Logo
Alkem Laboratories Ltd
NSE:ALKEM
Watchlist
Price: 5 406.2998 INR -1.38%
Market Cap: 646.4B INR
Have any thoughts about
Alkem Laboratories Ltd?
Write Note

Alkem Laboratories Ltd
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Alkem Laboratories Ltd
Net Income (Common) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Alkem Laboratories Ltd
NSE:ALKEM
Net Income (Common)
â‚ą20.5B
CAGR 3-Years
8%
CAGR 5-Years
20%
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Net Income (Common)
â‚ą53.4B
CAGR 3-Years
40%
CAGR 5-Years
14%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Net Income (Common)
â‚ą44.8B
CAGR 3-Years
20%
CAGR 5-Years
22%
CAGR 10-Years
15%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Net Income (Common)
â‚ą110.5B
CAGR 3-Years
21%
CAGR 5-Years
21%
CAGR 10-Years
6%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Net Income (Common)
â‚ą18B
CAGR 3-Years
12%
CAGR 5-Years
27%
CAGR 10-Years
8%
M
Mankind Pharma Ltd
NSE:MANKIND
Net Income (Common)
â‚ą19.1B
CAGR 3-Years
15%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Alkem Laboratories Ltd
Glance View

Market Cap
646.4B INR
Industry
Pharmaceuticals

Alkem Laboratories Ltd., founded in 1973, has emerged as a significant player in India's pharmaceutical landscape, deftly combining innovation with a robust distribution network. Anchored in Mumbai, Alkem began as a modest venture but quickly evolved into a powerhouse, renowned for manufacturing a broad spectrum of branded generics, over-the-counter products, and active pharmaceutical ingredients (APIs). The company's success lies in its ability to cater to both domestic and international markets, primarily thriving on the ever-increasing demand for affordable healthcare solutions. Its formidable market presence in India is supported by a strong sales force and an extensive distribution network, ensuring its therapies reach even the most remote corners of the country. Internationally, Alkem has carved a niche for itself, with the United States being one of its major export markets. It strategically entered this competitive arena, building a portfolio of ANDAs (Abbreviated New Drug Applications) that allowed it to provide lower-cost alternatives to big pharma's patented drugs. This not only fueled its revenue growth but also fortified its standing as a go-to source for quality generics. Alkem's research and development efforts underpin its commitment to healthcare innovation, as it constantly seeks to expand its therapeutic repertoire. By consistently focusing on quality, affordability, and resourceful adaptation to global healthcare needs, Alkem Laboratories Ltd. has managed to script a growth story that is both impressive and sustainable.

ALKEM Intrinsic Value
3 919.3728 INR
Overvaluation 28%
Intrinsic Value
Price

See Also

What is Alkem Laboratories Ltd's Net Income (Common)?
Net Income (Common)
20.5B INR

Based on the financial report for Jun 30, 2024, Alkem Laboratories Ltd's Net Income (Common) amounts to 20.5B INR.

What is Alkem Laboratories Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
20%

Over the last year, the Net Income (Common) growth was 80%. The average annual Net Income (Common) growth rates for Alkem Laboratories Ltd have been 8% over the past three years , 20% over the past five years .

Back to Top